公开(公告)号：US20190336488A1

公开(公告)日：2019-11-07

申请号：US16514167

申请日：2019-07-17

Applicant: PRILENIA NEUROTHERAPEUTICS LTD. ,  NATIONAL UNIVERSITY OF SINGAPORE ,  AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH

Inventor： Michael HAYDEN ,  Mahmoud Abdulhossein POULADI

IPC: A61K31/451 ,  A61K9/00 ,  A61P43/00

Abstract: The invention provides a method of treating a subject afflicted with fragile X syndrome (FXS) or a FXS related disorder, comprising periodically administering to the subject a pharmaceutical composition comprising an amount of pridopidine effective to treat the subject.

公开(公告)号：US20210093622A1

公开(公告)日：2021-04-01

申请号：US17074901

申请日：2020-10-20

Applicant: PRILENIA NEUROTHERAPEUTICS LTD.

Inventor： Michael HAYDEN ,  Mahmoud Abdulhossein POULADI

IPC: A61K31/4453 ,  A61K9/00 ,  A61P25/24 ,  A61K9/48 ,  A61P25/22

Abstract: The invention provides a method of reducing anxiety and/or depression in a subject comprising periodically administering to the subject a pharmaceutical composition comprising an amount of pridopidine effective to reduce anxiety and/or depression in a subject.

公开(公告)号：US20220202798A1

公开(公告)日：2022-06-30

申请号：US17588403

申请日：2022-01-31

Applicant: PRILENIA NEUROTHERAPEUTICS LTD. ,  NATIONAL UNIVERSITY OF SINGAPORE ,  AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH

Inventor： Michael HAYDEN ,  Mahmoud Abdulhossein POULADI

IPC: A61K31/451 ,  A61P43/00 ,  A61K9/00

Abstract: The invention provides a method of treating a subject afflicted with fragile X syndrome (FXS) or a FXS related disorder, comprising periodically administering to the subject a pharmaceutical composition comprising an amount of pridopidine effective to treat the subject.